SFX by Ex Libris Inc.

Title:	Discovery and Structure-Based Optimization of Adenain Inhibitors
Source:	Acs Medicinal Chemistry Letters [1948-5875] Mac Sweeney, Aengus yr:2014

Basic

Full text

Full text available via American Chemical Society Journals

Year:

Volume:

Issue:

Start Page:

Full text available via PubMed Central

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	"Researchers from Novartis Institute for Biomedical Research Provide Details of New Studies and Findings in the Area of Medicinal Chemistry (Discovery and Structure-Based Optimization of Adenain Inhibitors)." Health & medicine week. 3947-.
description	2.	Parsy, C. "Structure-based design of a novel series of azetidine inhibitors of the hepatitis C virus NS3/4A serine protease." Bioorganic and medicinal chemistry letters 24.18 (2014): 4444-4449.
description	3.	Netea, Mihai G. "Genetic variation in Toll-like receptors and disease susceptibility." Nature Immunology 13.6 (2012): 535-542.
description	4.	Budulac, Simona E. "Toll-Like Receptor (TLR2 and TLR4) Polymorphisms and Chronic Obstructive Pulmonary Disease." PLoS ONE 7.8 (2012).
description	5.	"Bioinformatics perspective on rhomboid intramembrane protease evolution and function." Biochimica et biophysica acta. 1828.12: 2937-2943.
description	6.	Arbour, N C C. "TLR4 mutations are associated with endotoxin hyporesponsiveness in humans." Nature genetics 25.2 (2000): 187-91.
description	7.	Casanova, J. "Perspective - Primary immunodeficiencies: A field in its infancy." Science 317.5838 (2007): 617-619.
description	8.	Mudd, B. "CD36 is a sensor of diacylglycerides." Nature 433.7025: 523-527.
description	9.	Misch, E Ann A. "Toll-like receptor polymorphisms and susceptibility to human disease." Clinical science 114.5 (1979): 347-60.
description	10.	Furusawa, T. "Hypertension-susceptibility gene prevalence in the Pacific Islands and associations with hypertension in Melanesia." Journal of human genetics 58.3 (2013): 142-149.
description	11.	Poltorak, A. "Sepsis and evolution of the innate immune response." Critical care medicine 29.7 (2001): 2-6.
description	12.	Schwartz, D A. "Polymorphisms of the toll-like receptors and human disease." Clinical infectious diseases 41.10 (2005): 403-7.
description	13.	Lorenz, E. "Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock." Archives of internal medicine 162.9 (2002): 1028-32.
description	14.	Ottenhoff, Tom H M H. "Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae." Nature genetics 32.1: 97-105.
description	15.	Watson, C. "Role of Chlamydia pneumoniae in atherosclerosis." Clinical science 114.8 (2008): 509-31.
description	16.	Dominy, Brian J. "The Evolution of Catalytic Function in the HIV-1 Protease." Journal of Molecular Biology 408.4 (2011): 792-805.
description	17.	Lowrance, W. "Ethics - Identifiability in genomic research." Science 317.5838 (2007): 600-602.
description	18.	Anglister, J. "Correlated mutations at gp120 positions 322 and 440: Implications for gp120 structure." Proteins 71.3 (2008): 1066-70.
description	19.	Torres, R. "Mutation screening of the Wolfram syndrome gene in psychiatric patients." Molecular psychiatry 6.1 (2000): 39-43.
description	20.	Vogel, Stefanie N N. "Mutations in TLR4 signaling that lead to increased susceptibility to infection in humans: an overview." Journal of endotoxin research 11.6: 333-339.